Literature DB >> 27108014

Clinical impact of the lower limit of normal of FEV1/FVC on survival in lung cancer patients undergoing thoracic surgery.

Asuka Matsuzaki1, Naozumi Hashimoto2, Shotaro Okachi3, Tetsuo Taniguchi4, Koji Kawaguchi5, Takayuki Fukui6, Kenji Wakai7, Kohei Yokoi8, Yoshinori Hasegawa9.   

Abstract

BACKGROUND: Previously, it has been shown that using a fixed ratio of FEV1/FVC of 0.7 to classify airway obstruction could not predict survival outcomes in lung cancer patients undergoing thoracic surgery. We demonstrated that use of the lower limit of normal (LLN) of FEV1/FVC may allow better risk stratification for postoperative outcomes in patients with chronic obstructive pulmonary disease (COPD) patients. Nevertheless, it remained unclear whether survival outcomes in this population could be predicted by LLN-defined airway obstruction.
OBJECTIVE: To evaluate the clinical relevance of LLN-defined airway obstruction to survival outcomes.
METHODS: The clinical relevance of LLN-defined airway obstruction was analyzed and compared in 699 subjects, using Kaplan-Meier curves and the log-rank test. A Cox regression model was used to explore prognostic risk factors.
RESULTS: One hundred-and-seventy-eight subjects were assigned to the below-LLN group, in which airflow obstruction determined by the FEV1/FVC ratio was below the LLN. Five hundred-and-twenty-one subjects were assigned to the above-LLN group. The below-LLN group had a worse overall survival (OS) and disease-free survival (DFS) than the above-LLN group. The diffusing capacity of the lung for carbon monoxide and the ratio of the inspiratory capacity divided to the total lung capacity were independent risk factors for OS and DFS.
CONCLUSIONS: A standardized assessment of LLN-defined airway obstruction may allow risk stratification for survival likelihood in lung cancer patients who undergo thoracic surgery.
Copyright © 2015 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic obstructive lung disease; Lower limit of normal; Lung cancer; Survival; Thoracic surgery

Mesh:

Year:  2015        PMID: 27108014     DOI: 10.1016/j.resinv.2015.11.006

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  7 in total

1.  Maximal voluntary ventilation and forced vital capacity of pulmonary function are independent prognostic factors in colorectal cancer patients: A retrospective study of 2323 cases in a single-center of China.

Authors:  Jiangpeng Wei; Ying Zhang; Pengfei Yu; Xiuqin Li; Xiangying Feng; Shisen Li; Gang Ji; Xiaohua Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

2.  Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.

Authors:  Naozumi Hashimoto; Akira Ando; Shingo Iwano; Koji Sakamoto; Shotaro Okachi; Asuka Matsuzaki; Yu Okada; Kenji Wakai; Kohei Yokoi; Yoshinori Hasegawa
Journal:  BMC Pulm Med       Date:  2018-01-05       Impact factor: 3.317

3.  Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.

Authors:  Norihito Omote; Naozumi Hashimoto; Masahiro Morise; Koji Sakamoto; Shinichi Miyazaki; Akira Ando; Yoshio Nakahara; Yoshinori Hasegawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-11

4.  Low forced vital capacity predicts poor prognosis in gastric cancer patients.

Authors:  Fan Feng; Yangzi Tian; Yuan Zang; Li Sun; Liu Hong; Jianjun Yang; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  Oncotarget       Date:  2017-04-25

5.  Pulmonary function impairment predicted poor prognosis of patients with hepatocellular carcinoma after hepatectomy.

Authors:  Yanhua Zhao; Shusheng Leng; Dongdong Li; Shu Feng; Zhonghao Wang; Chuanmin Tao
Journal:  Oncotarget       Date:  2017-09-12

6.  <Editors' Choice> Renewed Japanese spirometric reference variables and risk stratification for postoperative outcomes in COPD patients with resected lung cancer.

Authors:  Yu Okada; Naozumi Hashimoto; Shingo Iwano; Koji Kawaguchi; Takayuki Fukui; Koji Sakamoto; Kenji Wakai; Kohei Yokoi; Yoshinori Hasegawa
Journal:  Nagoya J Med Sci       Date:  2019-08       Impact factor: 1.131

7.  Prediction of Overall Survival of Patients with Completely Resected Non-Small Cell Lung Cancer: Analyses of Preoperative Spirometry, Preoperative Blood Tests, and Other Clinicopathological Data.

Authors:  Mengkun Shi; Cheng Zhan; Jialun Shi; Qun Wang
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.